Company overview
Proteintech manufactures over 15,000 antibodies, ELISA kits, and recombinant proteins targeting more than 13,500 human proteins, covering two-thirds of the proteome for applications including WB, IHC, IF, FC, and ELISA. The company offers polyclonal, monoclonal, and recombinant antibodies, along with GMP-grade cytokines and growth factors for cell and gene therapies following recent ISO accreditation. Their Able AI tool provides smart reagent recommendations, experimental design support, and validation data to accelerate research workflows.
Antibodies is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents partner serving United States & Americas. Core focus areas include proteintech antibodies, elisa kits, recombinant proteins, able ai reagent selection, gmp cytokines.
Industry categories: Life Science Reagents. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Antibodies include Reagent, Elisa — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.ptglab.com
- Categories
- Life Science Reagents
- Markets served
- United States & Americas
- Keywords
- proteintech antibodies, elisa kits, recombinant proteins, able ai reagent selection, gmp cytokines
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What products does Proteintech offer for life sciences research?
- Proteintech provides over 15,000 self-manufactured antibodies, ELISA kits, and recombinant proteins targeting 13,500+ proteins for WB, IHC, IF, FC, and ELISA applications.
- Does Proteintech support custom services and regulatory compliance?
- Yes, they offer custom conjugation services and GMP-grade cytokines/growth factors for cell and gene therapies, with recent ISO accreditation.
- What is Able AI and how does it help researchers?
- Able AI is an AI-powered tool for reagent selection and experimental design, offering antibody recommendations, validation data, controls, and protocols based on proprietary datasets.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
